Palantir Technologies, the US data analytics firm, is at the center of heated debate right now. Its stock took a hit in early April 2026, dropping as investors reacted to slowing growth signals after a strong 2025, though revenue forecasts for the year still point to around 61% growth to $7.19 billion. On the flip side, over 100 European banks, asset managers, and funds boosted stakes by more than 60% last year, pushing total investments to about $27 billion by late 2025, led by Norway's Norges Bank with $5.1 billion.
What's the fuss about? Critics slam Palantir for morally shaky work, like software for US ICE deportations and Israeli military ops in Gaza, earning it a dismal 2/10 on human rights from MSCI. Amnesty called it out back in 2020 for rights issues, and founder Peter Thiel's anti-EU, pro-Trump stance doesn't help. Europe's hooked anyway: UK MoD uses it heavily despite insider warnings of security risks from data access; NHS has a £330m deal; Spain's Defense got €16.5m for intel databases; Netherlands army deploys it secretly; Germany bans it federally but some states use it; even EU handed patient data during COVID.
This EU embed worries folks on digital independence. Experts like Francesca Bria say it's like handing sovereignty to US security via software, as Palantir aggregates sensitive data across systems. Switzerland nixed deals over sovereignty risks, suing reporters who covered it; Norway's Storebrand dumped shares over Gaza links. Yet big players like Barclays ($2.2B), Deutsche Bank ($2B), BNP Paribas ($1B+) keep piling in via index funds, skipping exclusion lists despite OECD human rights guidelines. Palantir claims it bolsters Western democracies, aiding health, defense, and ops like Ukraine support.
Balancing act: huge commercial wins and AI edge versus ethical red flags and sovereignty threats. For Europe, it's convenience versus control, especially as AI warfare tools speed kill chains from days to minutes.
